The Latest Data for Ruxolitinib Cream in Vitiligo: Finding Context from the Outcomes
home / medcast / the-latest-data-for-ruxolitinib-cream-in-vitiligo-finding-context-from-the-outcomes
Dermatologists Raj Chovatiya, MD, PhD, and David Rosmarin, MD, discuss new research outcomes for the topical JAK inhibitor live from the Revolutionizing Atopic Dermatiti 2023 Annual Meeting in Washington, DC.
The Latest Data for Ruxolitinib Cream in Vitiligo: Finding Context from the Outcomes
May 10th 2023Dermatologists Raj Chovatiya, MD, PhD, and David Rosmarin, MD, discuss new research outcomes for the topical JAK inhibitor live from the Revolutionizing Atopic Dermatiti 2023 Annual Meeting in Washington, DC.
